Are Purshottam Inves latest results good or bad?

Nov 07 2025 07:19 PM IST
share
Share Via
Purshottam Investofin's latest results are poor, showing a net loss of ₹2.04 crores and an 83.10% year-on-year revenue decline, indicating severe operational challenges and governance concerns. The company's stock has underperformed significantly, making it a high-risk investment.
Purshottam Investofin's latest financial results indicate significant operational challenges. In the second quarter of FY26, the company reported a net loss of ₹2.04 crores, which represents a substantial decline compared to the average of the previous four quarters. This loss is compounded by a dramatic drop in revenue, with six-month revenue totaling ₹5.09 crores, reflecting an 83.10% decrease year-on-year. Such a decline highlights a severe breakdown in the company's lending operations.

The operating profit before depreciation, interest, and tax (PBDIT) for Q2 FY26 was recorded at ₹-1.62 crores, marking the lowest figure on record. The company's earnings per share (EPS) also reached a record low of ₹-2.75, underscoring the pressure on shareholder value. Furthermore, the return on equity (ROE) over the past five years stands at 8.86%, but the latest figure of 1.88% signals a sharp decline in capital efficiency.

Purshottam Investofin's capital structure appears fragile, with zero promoter holding and minimal institutional interest, which raises governance concerns. The company's debt-to-equity ratio of 0.45 suggests low financial leverage, but this reflects challenges in accessing debt markets rather than effective financial management.

The stock has underperformed significantly, with a decline of 25.62% over the past year compared to a gain in the Sensex. The volatility of the stock, along with its negative risk-adjusted returns, positions it as a high-risk investment.

Overall, Purshottam Investofin's financial performance reveals a company grappling with severe operational difficulties, a collapsing revenue base, and significant governance issues. The company saw an adjustment in its evaluation, reflecting these ongoing challenges and the lack of a clear path to recovery.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News